. . . . . . . "[findings show that amplification of MET causes gefitinib resistance in lung cancer by driving ERBB3 (HER3) -dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:31+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .